Home 2018-07-18T12:14:50+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Great trend. More #OpenScience! Researchers create largest publicly available virtual library of >1 million macrolide scaffolds that will help find new antibiotics or cancer drugs https://t.co/vPn26qmSJm

The first hour summarizes well @M4KPharma's progress toward an ALK2 drug. Thanks to all who are contributing! #openscience #opendrugdiscovery #affordablemedicines https://t.co/gM9oYD94lE

Listen to our Dec mtg to learn what we've been up to over our first year including the discovery of M4K2009, a selective, brain penetrant and orally bioavailable ALK2 inhibitor that we will share with the scientific community #sharingiscaring #openscience https://t.co/ys10PD7wh4

Missed our December meeting? Listen to it here: https://t.co/ys10PD7wh4 #openscience

Liz Brown @thesgconline compares the activity of ALK2 inhibitors from @M4KPharma in #DIPG cells carrying mutant or wild-type ALK2. #Openscience notebook: https://t.co/68pPhxcJlo Blog: https://t.co/Pcrs7waiSR @DefeatDIPG @AbbiesArmy

Load More...

Latest Blog Posts